Oak Harbor Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Oak Harbor Wealth Partners's BMY Position: Q1 2026 in Review
Oak Harbor Wealth Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.55% in Q1 2026, selling an estimated $1.46K and leaving 4,525 shares worth $274K. The position accounts for 0.06% of the portfolio, ranked #174.
Oak Harbor Wealth Partners first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $511K in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Oak Harbor Wealth Partners held 4,525 shares of Bristol-Myers Squibb worth $274K as of Q1 2026.
- Oak Harbor Wealth Partners sold 25 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.46K.
- Bristol-Myers Squibb made up 0.06% of Oak Harbor Wealth Partners's portfolio in Q1 2026, its #174 holding.
- Oak Harbor Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
- Oak Harbor Wealth Partners's Bristol-Myers Squibb position peaked at $511K in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Oak Harbor Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.